‘Abortion pill’ found to have ‘severe adverse effects’ for 1 in 10 women, study finds

A new inquiry has exposed serious adverse events linked to mifepristone also known as the abortion pill Mifepristone is a pregnancy blocker that is used in combination with another medication misoprostol to terminate pregnancies according to Mayo Clinic It is also used to manage early miscarriages as it helps prepare the body to empty the uterus ABORTION PILL USE HAS SPIKED IN NEWEST YEARS NEW SUMMARY REVEALS SUBSTANTIAL INCREASE Research by the Ethics Constituents Approach Center in Washington D C has revealed that the rate of serious side effects is times higher than what is indicated on the FDA-approved drug label After going through an abortion assisted by mifepristone nearly of women more than one in released experiencing infection hemorrhaging or another serious or life-threatening adverse event according to the assessment summary The investigation used insurance alleges details that includes more than medication abortions prescribed between and resulting in what is described as the largest-ever dataset on chemical abortion ABORTION ON DEMAND THESE STATES ALLOW WOMEN TO GET PREGNANCY-ENDING DRUGS BY PHONE OR ONLINE By contrast the current FDA-approved drug label is based on the results of clinical trials with a total of women less than percent of whom reportedly experienced severe adverse reactions the investigation states Selected of these trials were conducted as long as years ago The evaluation authors Jamie Bryan Hall EPPC s director of information analysis and Ryan T Anderson EPPC s president called the results a truly shocking and sad reality We weren't exactly surprised by these findings as other studies of smaller datasets have revealed vital safety problems with chemical abortion drugs particularly after the Obama and Biden administrations removed significant FDA safety protections that were required when the chemical abortion drug was first approved the authors commented in a comment sent to Fox News Digital The largest limitation which we're working to address is that there is no insurance code for death and sadly we know that women die from complications resulting from the abortion pill Based on the evaluation the researchers are calling on the FDA to reinstate the original safety protections that they required when they approved mifepristone stating that women deserve the truth Christina Francis M D CEO of the American Association of Pro Life OBGYNs who is based in Ft Wayne Indiana was not involved in the research but commented on the significance of the outcome The findings of this evaluation which analyzes nearly drug-induced abortions align with what I have seen in my two decades of practice as an OB-GYN during which I have cared for numerous women who have been lied to about the safety of abortion drugs and suffered key complications from them she reported Fox News Digital Francis concluded that nearly women likely suffered these types of severe complications in based on numbers from the Guttmacher Institute This should serve as a wake-up call for the FDA that the complication rate is over times higher than what has previously stated and is a community soundness emergency that should be investigated this instant she declared Women deserve informed consent about the potentially life-threatening dangers of these drugs Professor Jessie Hill a physical condition law expert at Occurrence Western Reserve University in Cleveland Ohio also reviewed the research findings She stated that mifepristone has been one of the most-studied medications ever since its approval in the U S years ago claiming it is also one of the safest CLICK HERE TO SIGN UP FOR OUR FITNESS NEWSLETTERHill pointed out that the EPPC s inquiry is not peer-reviewed and questioned its probable bias The evaluation uses insurance declares content but insurance contends are an imperfect proxy for causal clinical outcomes she narrated Fox News Digital They often lack context a claim for hemorrhage for instance may not even be causally linked to mifepristone itself Hill also objected to the comparison of modern declares material to the FDA s clinical trial facts Clinical trials have rigorous standards for defining and reporting adverse events Maintains content are generated for billing purposes not scientific analysis and often overcount or misclassify events Hill also noted that the legal standard for FDA drug regulation is not no exposure and that all medications have adverse event rates Overstating risks without weighing benefits distorts the regulatory framework she stated For more Vitality articles visit www foxnews com healthApproximately of all abortions in the U S in were medication abortions according to the Guttmacher Institute This was an increase from in Fox News Digital reached out to the FDA and to the manufacturer of mifepristone for comment